Rikke Hjortebjerg

Palle Juul Jensens Boulevard 165
Aarhus N, 8200, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Prospective Short- and Long-Term Changes in Cardiometabolic Risk Markers Following Gender-Affirming Hormone Therapy.

Prospective Short- and Long-Term Changes in Cardiometabolic Risk Markers Following Gender-Affirming Hormone Therapy.

Journal: Andrology

Published: January 27, 2026

IGF-PAPP-A-stanniocalcin axis and androgenic anabolic steroid use in men and women.

IGF-PAPP-A-stanniocalcin axis and androgenic anabolic steroid use in men and women.

Journal: European journal of endocrinology

Published: October 16, 2025

Illicit Anabolic Steroid Use and Cardiovascular Status in Men and Women.

Illicit Anabolic Steroid Use and Cardiovascular Status in Men and Women.

Journal: JAMA network open

Published: August 29, 2025

Muscle Strength and Power Changes With Gender-Affirming Hormone Therapy.

Muscle Strength and Power Changes With Gender-Affirming Hormone Therapy.

Journal: Andrology

Published: June 08, 2025

Cardiac function and coronary plaque development following masculinizing gender-affirming hormone therapy: A prospective cohort study.

Cardiac function and coronary plaque development following masculinizing gender-affirming hormone therapy: A prospective cohort study.

Journal: Andrology

Published: October 18, 2024

Growth hormone/insulin-like growth factor I axis in health and disease states: an update on the role of intra-portal insulin.

Growth hormone/insulin-like growth factor I axis in health and disease states: an update on the role of intra-portal insulin.

Journal: Frontiers in endocrinology

Published: June 28, 2024

The pro-atherogenic enzyme PAPP-A is active in eluates from human carotid and femoral atherosclerotic plaques.

The pro-atherogenic enzyme PAPP-A is active in eluates from human carotid and femoral atherosclerotic plaques.

Journal: Atherosclerosis plus

Published: May 17, 2024

The IGF-PAPP-A-Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with Ovarian Cancer.

The IGF-PAPP-A-Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with Ovarian Cancer.

Journal: International journal of molecular sciences

Published: January 11, 2024

Intravenous versus oral hydration to reduce the risk of postcontrast acute kidney injury after intravenous contrast-enhanced CT in patients with severe chronic kidney disease (ENRICH): a study protocol for a single-centre, parallel-group, open-labelled non-inferiority randomised controlled trial in Denmark.

Intravenous versus oral hydration to reduce the risk of postcontrast acute kidney injury after intravenous contrast-enhanced CT in patients with severe chronic kidney disease (ENRICH): a study protocol for a single-centre, parallel-group, open-labelled non-inferiority randomised controlled trial in Denmark.

Journal: BMJ open

Published: September 12, 2023

Associations between insulin-like growth factor binding protein-2 and insulin sensitivity, metformin, and mortality in persons with T2D.

Associations between insulin-like growth factor binding protein-2 and insulin sensitivity, metformin, and mortality in persons with T2D.

Journal: Diabetes research and clinical practice

Published: July 04, 2023

Heritability and circulating concentrations of pregnancy-associated plasma protein-A and stanniocalcin-2 in elderly monozygotic and dizygotic twins.

Heritability and circulating concentrations of pregnancy-associated plasma protein-A and stanniocalcin-2 in elderly monozygotic and dizygotic twins.

Journal: Frontiers in endocrinology

Published: March 25, 2023

The STC2-PAPP-A-IGFBP4-IGF1 axis and its associations to mortality and CVD in T2D.

The STC2-PAPP-A-IGFBP4-IGF1 axis and its associations to mortality and CVD in T2D.

Journal: Endocrine connections

Published: December 20, 2022

Showing 1-12 of 43

Last Updated: 09/26/2026